Darden Restaurant, Inc.’s plan to spin off its Red Lobster chain to divest debt won’t be enough to shore up the sagging stock, according to hedge-fund managers at Starboard Value, LP. The group divulged that it holds a 5.6 percent stake in Darden shares yesterday and announced that it will engage in talks with Darden management to see what other measures can be taken to strengthen share price — in addition to the company’s plan for a tax-free spinoff of Red Lobster. Starboard’s opinion was seconded by the Burlington Capital Group LP, which holds about 2.8 percent of Darden’s stock. Burlington Capital citied slowing sales momentum and a 13 percent rise in share price – with the industry average standing at around 22 percent — as reasons for seeking additional operational changes to the international restaurant chain. So how did this flurry of negative news affect Darden’s share price last week? Not so much, as shares lost only 0.1 percent.
Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:
Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.
Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:
Jon Johnson's philosophy in investing and trading is to take what the market gives you regardless if that is to the upside or downside. For the past 21 years, Jon has helped thousands of clients gain success in the financial markets through his newsletters and education services:
Get free access to "Millionaire Maker" Hilary Kramer's latest report 3 Biotech Breakthroughs To Bank On. Simply tell us where to send it in the box below.
*Along with my FREE report, Hilary Kramer's
3 Biotech Breakthroughs to Bank On, please also send Hilary's free weekly e-letter, Trading Desk. We value your privacy. You will not be spammed, ever. Period.